Tag: white house

July 15, 2018

5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top

Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ...
July 3, 2018

4 Top Biotech Stocks on the TSX Year-to-Date

Which biotech stocks on the TSX have performed the best year-to-date? These four companies have risen to the top of...
July 1, 2018

5 Top Weekly NASDAQ Biotech Stocks: Avid Bioservices on Top

Avid Bioservices, Arbutus Biopharma, Catalyst, ArQule and CTI BioPharma were last week's top gainers on the NASDAQ Biotechnology Index.
June 10, 2018

5 Top Weekly NASDAQ Biotech Stocks: MEI Pharma on Top

MEI Pharma, Anavex Life Sciences, Trillium Therapeutics, Celldex Therapeutics and Ophthotech were last week's top gainers on the NASDAQ Biotechnology...
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 1, 2018

Steel and Aluminum Tariffs Deadline Pushed to June 1

Just hours before tariff exemptions were set to be lifted, US President Donald Trump extended the decision deadline to June...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 27, 2018

MDC Partners Appoints Desirée Rogers as Independent Director to its Board

MDC Partners Inc (NASDAQ:MDCA), one of the fastest growing and influential marketing and communications networks in the world announced today...
April 15, 2018

5 Top Weekly NASDAQ Biotech Stocks: Novelion on Top

Novelion Therapeutics, EyePoint Pharmaceuticals, CytRx, Viking Therapeutics and AVEO Pharmaceuticals were last week's top gainers.
April 3, 2018

China Strikes Back at US With $3 Billion in Tariffs

As China and the US get into a tit-for-tat contest of tariffs, experts are worried more about escalation than a...